Monthly shot tested to help hospital patients stay in opioid treatment
NCT ID NCT04345718
Summary
This study tested whether a single monthly injection of buprenorphine (XR-BUP) helps hospitalized patients with opioid addiction stay in treatment better than standard care after they go home. About 344 adults with moderate to severe opioid use disorder were randomly assigned to receive either the injection or standard treatment options like daily medications. Researchers checked if participants were still receiving legitimate addiction treatment one month after leaving the hospital, with follow-ups at three and six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBSTANCE USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Boston University
Boston, Massachusetts, 02118, United States
-
Hennepin Healthcare Research Institute
Minneapolis, Minnesota, 55404, United States
-
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
-
Yale New Haven Hospital
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.